Market Executive Summary
Due to the COVID-19 pandemic, the global Cell Lysis & Disruption market size was US$ 91 million in 2022 and is forecast to a readjusted size of US$ 131.1 million by 2029 with a CAGR of 4.9% during the forecast period 2023-2029.
Lysis refers to the breaking down of the membrane of a cell, often by viral, enzymic, or osmotic mechanisms that compromise its integrity. A fluid containing the contents of lysed cells is called a lysate. Cell disruption is a method or process for releasing biological molecules from inside a cell.
The market is growing because the higher adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Cell Lysis & Disruption market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Cell Lysis & Disruption market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Cell Lysis & Disruption market. Readers of the report can become informed about current and future trends of the global Cell Lysis & Disruption market and how they will impact market growth during the forecast period.
By Company
Thermo Fisher Scientific, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd
Qiagen NV
Becton Dickinson & Company (BD)
Danaher Corporation
Bio-Rad Laboratories, Inc.
Miltenyi Biotec GmbH
Claremont BioSolutions, LLC
Microfluidics International Corporation
Parr Instrument Company
BioVision, Inc.
Covaris, Inc.
Qsonica LLC
Segment by Type
Mammalian cells
Bacterial cells
Yeast/Algae/Fungi
Plant cells
Segment by Application
Protein Isolation
Downstream Processing
Cell Organelle Isolation
Nucleic Acid Isolation
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Cell Lysis & Disruption in global and regional level.
Chapter 3: Detailed analysis of Cell Lysis & Disruption companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Lysis & Disruption revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Lysis & Disruption Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mammalian cells
1.2.3 Bacterial cells
1.2.4 Yeast/Algae/Fungi
1.2.5 Plant cells
1.3 Market by Application
1.3.1 Global Cell Lysis & Disruption Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 Protein Isolation
1.3.3 Downstream Processing
1.3.4 Cell Organelle Isolation
1.3.5 Nucleic Acid Isolation
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Cell Lysis & Disruption Market Size (2018-2029)
2.2 Cell Lysis & Disruption Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global Cell Lysis & Disruption Market Size by Region (2018-2023)
2.4 Global Cell Lysis & Disruption Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 Cell Lysis & Disruption Countries Ranking by Market Size
3 Cell Lysis & Disruption Competitive by Company
3.1 Global Cell Lysis & Disruption Revenue by Players
3.1.1 Global Cell Lysis & Disruption Revenue by Players (2018-2023)
3.1.2 Global Cell Lysis & Disruption Market Share by Players (2018-2023)
3.2 Global Cell Lysis & Disruption Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Cell Lysis & Disruption Revenue
3.4 Global Cell Lysis & Disruption Market Concentration Ratio
3.4.1 Global Cell Lysis & Disruption Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Lysis & Disruption Revenue in 2022
3.5 Global Key Players of Cell Lysis & Disruption Head office and Area Served
3.6 Global Key Players of Cell Lysis & Disruption, Product and Application
3.7 Global Key Players of Cell Lysis & Disruption, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Cell Lysis & Disruption Breakdown Data by Type
4.1 Global Cell Lysis & Disruption Historic Revenue by Type (2018-2023)
4.2 Global Cell Lysis & Disruption Forecasted Revenue by Type (2024-2029)
5 Global Cell Lysis & Disruption Breakdown Data by Application
5.1 Global Cell Lysis & Disruption Historic Market Size by Application (2018-2023)
5.2 Global Cell Lysis & Disruption Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Lysis & Disruption Revenue by Company (2021-2023)
6.2 North America Cell Lysis & Disruption Revenue by Type (2018-2029)
6.3 North America Cell Lysis & Disruption Revenue by Application (2018-2029)
6.4 North America Cell Lysis & Disruption Revenue by Country (2018-2029)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Cell Lysis & Disruption Revenue by Company (2021-2023)
7.2 Europe Cell Lysis & Disruption Revenue by Type (2018-2029)
7.3 Europe Cell Lysis & Disruption Revenue by Application (2018-2029)
7.4 Europe Cell Lysis & Disruption Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Cell Lysis & Disruption Revenue by Company (2021-2023)
8.2 Asia Pacific Cell Lysis & Disruption Revenue by Type (2018-2029)
8.3 Asia Pacific Cell Lysis & Disruption Revenue by Application (2018-2029)
8.4 Asia Pacific Cell Lysis & Disruption Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Cell Lysis & Disruption Revenue by Company (2021-2023)
9.2 Latin America Cell Lysis & Disruption Revenue by Type (2018-2029)
9.3 Latin America Cell Lysis & Disruption Revenue by Application (2018-2029)
9.4 Latin America Cell Lysis & Disruption Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cell Lysis & Disruption Revenue by Company (2021-2023)
10.2 Middle East and Africa Cell Lysis & Disruption Revenue by Type (2018-2029)
10.3 Middle East and Africa Cell Lysis & Disruption Revenue by Application (2018-2029)
10.4 Middle East and Africa Cell Lysis & Disruption Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Products and Services
11.1.4 Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.1.5 Thermo Fisher Scientific, Inc. Cell Lysis & Disruption SWOT Analysis
11.1.6 Thermo Fisher Scientific, Inc. Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Cell Lysis & Disruption Products and Services
11.2.4 Merck KGaA Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.2.5 Merck KGaA Cell Lysis & Disruption SWOT Analysis
11.2.6 Merck KGaA Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Products and Services
11.3.4 F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Ltd Cell Lysis & Disruption SWOT Analysis
11.3.6 F. Hoffmann-La Roche Ltd Recent Development
11.4 Qiagen NV
11.4.1 Qiagen NV Company Details
11.4.2 Qiagen NV Business Overview
11.4.3 Qiagen NV Cell Lysis & Disruption Products and Services
11.4.4 Qiagen NV Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.4.5 Qiagen NV Cell Lysis & Disruption SWOT Analysis
11.4.6 Qiagen NV Recent Development
11.5 Becton Dickinson & Company (BD)
11.5.1 Becton Dickinson & Company (BD) Company Details
11.5.2 Becton Dickinson & Company (BD) Business Overview
11.5.3 Becton Dickinson & Company (BD) Cell Lysis & Disruption Products and Services
11.5.4 Becton Dickinson & Company (BD) Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.5.5 Becton Dickinson & Company (BD) Cell Lysis & Disruption SWOT Analysis
11.5.6 Becton Dickinson & Company (BD) Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Cell Lysis & Disruption Products and Services
11.6.4 Danaher Corporation Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.6.5 Danaher Corporation Cell Lysis & Disruption SWOT Analysis
11.6.6 Danaher Corporation Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Products and Services
11.7.4 Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.7.5 Bio-Rad Laboratories, Inc. Cell Lysis & Disruption SWOT Analysis
11.7.6 Bio-Rad Laboratories, Inc. Recent Development
11.8 Miltenyi Biotec GmbH
11.8.1 Miltenyi Biotec GmbH Company Details
11.8.2 Miltenyi Biotec GmbH Business Overview
11.8.3 Miltenyi Biotec GmbH Cell Lysis & Disruption Products and Services
11.8.4 Miltenyi Biotec GmbH Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.8.5 Miltenyi Biotec GmbH Cell Lysis & Disruption SWOT Analysis
11.8.6 Miltenyi Biotec GmbH Recent Development
11.9 Claremont BioSolutions, LLC
11.9.1 Claremont BioSolutions, LLC Company Details
11.9.2 Claremont BioSolutions, LLC Business Overview
11.9.3 Claremont BioSolutions, LLC Cell Lysis & Disruption Products and Services
11.9.4 Claremont BioSolutions, LLC Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.9.5 Claremont BioSolutions, LLC Cell Lysis & Disruption SWOT Analysis
11.9.6 Claremont BioSolutions, LLC Recent Development
11.10 Microfluidics International Corporation
11.10.1 Microfluidics International Corporation Company Details
11.10.2 Microfluidics International Corporation Business Overview
11.10.3 Microfluidics International Corporation Cell Lysis & Disruption Products and Services
11.10.4 Microfluidics International Corporation Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.10.5 Microfluidics International Corporation Cell Lysis & Disruption SWOT Analysis
11.10.6 Microfluidics International Corporation Recent Development
11.11 Parr Instrument Company
11.11.1 Parr Instrument Company Company Details
11.11.2 Parr Instrument Company Business Overview
11.11.3 Parr Instrument Company Cell Lysis & Disruption Products and Services
11.11.4 Parr Instrument Company Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.11.5 Parr Instrument Company Recent Development
11.12 BioVision, Inc.
11.12.1 BioVision, Inc. Company Details
11.12.2 BioVision, Inc. Business Overview
11.12.3 BioVision, Inc. Cell Lysis & Disruption Products and Services
11.12.4 BioVision, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.12.5 BioVision, Inc. Recent Development
11.13 Covaris, Inc.
11.13.1 Covaris, Inc. Company Details
11.13.2 Covaris, Inc. Business Overview
11.13.3 Covaris, Inc. Cell Lysis & Disruption Products and Services
11.13.4 Covaris, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.13.5 Covaris, Inc. Recent Development
11.14 Qsonica LLC
11.14.1 Qsonica LLC Company Details
11.14.2 Qsonica LLC Business Overview
11.14.3 Qsonica LLC Cell Lysis & Disruption Products and Services
11.14.4 Qsonica LLC Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023)
11.14.5 Qsonica LLC Recent Development
12 Cell Lysis & Disruption Market Dynamics
12.1 Cell Lysis & Disruption Industry Trends
12.2 Cell Lysis & Disruption Market Drivers
12.3 Cell Lysis & Disruption Market Challenges
12.4 Cell Lysis & Disruption Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Global Cell Lysis & Disruption Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Mammalian cells
Table 3. Key Players of Bacterial cells
Table 4. Key Players of Yeast/Algae/Fungi
Table 5. Key Players of Plant cells
Table 6. Global Cell Lysis & Disruption Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Cell Lysis & Disruption Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 8. Global Cell Lysis & Disruption Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Cell Lysis & Disruption Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 10. Global Cell Lysis & Disruption Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 11. Global Cell Lysis & Disruption Revenue by Players (2018-2023) & (US$ Million)
Table 12. Global Cell Lysis & Disruption Market Share by Players (2018-2023)
Table 13. Global Top Cell Lysis & Disruption Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Lysis & Disruption as of 2022)
Table 14. Ranking of Global Top Cell Lysis & Disruption Companies by Revenue (US$ Million) in 2022
Table 15. Global 5 Largest Players Market Share by Cell Lysis & Disruption Revenue (CR5 and HHI) & (2018-2023)
Table 16. Global Key Players of Cell Lysis & Disruption, Headquarters and Area Served
Table 17. Global Key Players of Cell Lysis & Disruption, Product and Application
Table 18. Global Key Players of Cell Lysis & Disruption, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Cell Lysis & Disruption Market Size by Type (2018-2023) & (US$ Million)
Table 21. Global Cell Lysis & Disruption Revenue Market Share by Type (2018-2023)
Table 22. Global Cell Lysis & Disruption Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 23. Global Cell Lysis & Disruption Revenue Market Share by Type (2024-2029)
Table 24. Global Cell Lysis & Disruption Market Size by Application (2018-2023) & (US$ Million)
Table 25. Global Cell Lysis & Disruption Revenue Market Share by Application (2018-2023)
Table 26. Global Cell Lysis & Disruption Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 27. Global Cell Lysis & Disruption Revenue Market Share by Application (2024-2029)
Table 28. North America Cell Lysis & Disruption Revenue by Company (2021-2023) & (US$ Million)
Table 29. North America Cell Lysis & Disruption Revenue by Type (2018-2023) & (US$ Million)
Table 30. North America Cell Lysis & Disruption Revenue by Type (2024-2029) & (US$ Million)
Table 31. North America Cell Lysis & Disruption Revenue by Application (2018-2023) & (US$ Million)
Table 32. North America Cell Lysis & Disruption Revenue by Application (2024-2029) & (US$ Million)
Table 33. North America Cell Lysis & Disruption Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Cell Lysis & Disruption Revenue by Country (2018-2023) & (US$ Million)
Table 35. North America Cell Lysis & Disruption Revenue by Country (2024-2029) & (US$ Million)
Table 36. Europe Cell Lysis & Disruption Revenue by Company (2021-2023) & (US$ Million)
Table 37. Europe Cell Lysis & Disruption Revenue by Type (2018-2023) & (US$ Million)
Table 38. Europe Cell Lysis & Disruption Revenue by Type (2024-2029) & (US$ Million)
Table 39. Europe Cell Lysis & Disruption Revenue by Application (2018-2023) & (US$ Million)
Table 40. Europe Cell Lysis & Disruption Revenue by Application (2024-2029) & (US$ Million)
Table 41. Europe Cell Lysis & Disruption Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Europe Cell Lysis & Disruption Revenue by Country (2018-2023) & (US$ Million)
Table 43. Europe Cell Lysis & Disruption Revenue by Country (2024-2029) & (US$ Million)
Table 44. Asia Pacific Cell Lysis & Disruption Revenue by Company (2021-2023) & (US$ Million)
Table 45. Asia Pacific Cell Lysis & Disruption Revenue by Type (2018-2023) & (US$ Million)
Table 46. Asia Pacific Cell Lysis & Disruption Revenue by Type (2024-2029) & (US$ Million)
Table 47. Asia Pacific Cell Lysis & Disruption Revenue by Application (2018-2023) & (US$ Million)
Table 48. Asia Pacific Cell Lysis & Disruption Revenue by Application (2024-2029) & (US$ Million)
Table 49. Asia-Pacific Cell Lysis & Disruption Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 50. Asia Pacific Cell Lysis & Disruption Revenue by Region (2018-2023) & (US$ Million)
Table 51. Asia Pacific Cell Lysis & Disruption Revenue by Region (2024-2029) & (US$ Million)
Table 52. Latin America Cell Lysis & Disruption Revenue by Company (2021-2023) & (US$ Million)
Table 53. Latin America Cell Lysis & Disruption Revenue by Type (2018-2023) & (US$ Million)
Table 54. Latin America Cell Lysis & Disruption Revenue by Type (2024-2029) & (US$ Million)
Table 55. Latin America Cell Lysis & Disruption Revenue by Application (2018-2023) & (US$ Million)
Table 56. Latin America Cell Lysis & Disruption Revenue by Application (2024-2029) & (US$ Million)
Table 57. Latin America Cell Lysis & Disruption Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 58. Latin America Cell Lysis & Disruption Revenue by Country (2018-2023) & (US$ Million)
Table 59. Latin America Cell Lysis & Disruption Revenue by Country (2024-2029) & (US$ Million)
Table 60. Middle East and Africa Cell Lysis & Disruption Revenue by Company (2021-2023) & (US$ Million)
Table 61. Middle East and Africa Cell Lysis & Disruption Revenue by Type (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Cell Lysis & Disruption Revenue by Type (2024-2029) & (US$ Million)
Table 63. Middle East and Africa Cell Lysis & Disruption Revenue by Application (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Cell Lysis & Disruption Revenue by Application (2024-2029) & (US$ Million)
Table 65. Middle East and Africa Cell Lysis & Disruption Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East and Africa Cell Lysis & Disruption Revenue by Country (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Cell Lysis & Disruption Revenue by Country (2024-2029) & (US$ Million)
Table 68. Thermo Fisher Scientific, Inc. Company Details
Table 69. Thermo Fisher Scientific, Inc. Business Overview
Table 70. Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Product and Services
Table 71. Thermo Fisher Scientific, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific, Inc. Cell Lysis & Disruption SWOT Analysis
Table 73. Thermo Fisher Scientific, Inc. Recent Development
Table 74. Merck KGaA Company Details
Table 75. Merck KGaA Business Overview
Table 76. Merck KGaA Cell Lysis & Disruption Product and Services
Table 77. Merck KGaA Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 78. Merck KGaA Cell Lysis & Disruption SWOT Analysis
Table 79. Merck KGaA Recent Development
Table 80. F. Hoffmann-La Roche Ltd Company Details
Table 81. F. Hoffmann-La Roche Ltd Business Overview
Table 82. F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Product and Services
Table 83. F. Hoffmann-La Roche Ltd Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 84. F. Hoffmann-La Roche Ltd Cell Lysis & Disruption SWOT Analysis
Table 85. F. Hoffmann-La Roche Ltd Recent Development
Table 86. Qiagen NV Company Details
Table 87. Qiagen NV Business Overview
Table 88. Qiagen NV Cell Lysis & Disruption Product and Services
Table 89. Qiagen NV Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 90. Qiagen NV Cell Lysis & Disruption SWOT Analysis
Table 91. Qiagen NV Recent Development
Table 92. Becton Dickinson & Company (BD) Company Details
Table 93. Becton Dickinson & Company (BD) Business Overview
Table 94. Becton Dickinson & Company (BD) Cell Lysis & Disruption Product and Services
Table 95. Becton Dickinson & Company (BD) Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 96. Becton Dickinson & Company (BD) Cell Lysis & Disruption SWOT Analysis
Table 97. Becton Dickinson & Company (BD) Recent Development
Table 98. Danaher Corporation Company Details
Table 99. Danaher Corporation Business Overview
Table 100. Danaher Corporation Cell Lysis & Disruption Product and Services
Table 101. Danaher Corporation Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 102. Danaher Corporation Cell Lysis & Disruption SWOT Analysis
Table 103. Danaher Corporation Recent Development
Table 104. Bio-Rad Laboratories, Inc. Company Details
Table 105. Bio-Rad Laboratories, Inc. Business Overview
Table 106. Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Product and Services
Table 107. Bio-Rad Laboratories, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 108. Bio-Rad Laboratories, Inc. Cell Lysis & Disruption SWOT Analysis
Table 109. Bio-Rad Laboratories, Inc. Recent Development
Table 110. Miltenyi Biotec GmbH Company Details
Table 111. Miltenyi Biotec GmbH Business Overview
Table 112. Miltenyi Biotec GmbH Cell Lysis & Disruption Product and Services
Table 113. Miltenyi Biotec GmbH Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 114. Miltenyi Biotec GmbH Cell Lysis & Disruption SWOT Analysis
Table 115. Miltenyi Biotec GmbH Recent Development
Table 116. Claremont BioSolutions, LLC Company Details
Table 117. Claremont BioSolutions, LLC Business Overview
Table 118. Claremont BioSolutions, LLC Cell Lysis & Disruption Product and Services
Table 119. Claremont BioSolutions, LLC Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 120. Claremont BioSolutions, LLC Cell Lysis & Disruption SWOT Analysis
Table 121. Claremont BioSolutions, LLC Recent Development
Table 122. Microfluidics International Corporation Company Details
Table 123. Microfluidics International Corporation Business Overview
Table 124. Microfluidics International Corporation Cell Lysis & Disruption Product and Services
Table 125. Microfluidics International Corporation Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 126. Microfluidics International Corporation Cell Lysis & Disruption SWOT Analysis
Table 127. Microfluidics International Corporation Recent Development
Table 128. Parr Instrument Company Company Details
Table 129. Parr Instrument Company Business Overview
Table 130. Parr Instrument Company Cell Lysis & Disruption Product and Services
Table 131. Parr Instrument Company Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 132. Parr Instrument Company Recent Development
Table 133. BioVision, Inc. Company Details
Table 134. BioVision, Inc. Business Overview
Table 135. BioVision, Inc. Cell Lysis & Disruption Product and Services
Table 136. BioVision, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 137. BioVision, Inc. Recent Development
Table 138. Covaris, Inc. Company Details
Table 139. Covaris, Inc. Business Overview
Table 140. Covaris, Inc. Cell Lysis & Disruption Product and Services
Table 141. Covaris, Inc. Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 142. Covaris, Inc. Recent Development
Table 143. Qsonica LLC Company Details
Table 144. Qsonica LLC Business Overview
Table 145. Qsonica LLC Cell Lysis & Disruption Product and Services
Table 146. Qsonica LLC Cell Lysis & Disruption Revenue in Cell Lysis & Disruption Business (2018-2023) & (US$ Million)
Table 147. Qsonica LLC Recent Development
Table 148. Cell Lysis & Disruption Market Trends
Table 149. Cell Lysis & Disruption Market Drivers
Table 150. Cell Lysis & Disruption Market Challenges
Table 151. Cell Lysis & Disruption Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell Lysis & Disruption Product Picture
Figure 2. Global Cell Lysis & Disruption Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global Cell Lysis & Disruption Market Share by Type: 2022 VS 2029
Figure 4. Mammalian cells Features
Figure 5. Bacterial cells Features
Figure 6. Yeast/Algae/Fungi Features
Figure 7. Plant cells Features
Figure 8. Global Cell Lysis & Disruption Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 9. Global Cell Lysis & Disruption Market Share by Application: 2022 VS 2029
Figure 10. Protein Isolation
Figure 11. Downstream Processing
Figure 12. Cell Organelle Isolation
Figure 13. Nucleic Acid Isolation
Figure 14. Cell Lysis & Disruption Report Years Considered
Figure 15. Global Cell Lysis & Disruption Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Cell Lysis & Disruption Market Size 2018-2029 (US$ Million)
Figure 17. Global Cell Lysis & Disruption Market Size Market Share by Region: 2022 VS 2029
Figure 18. Global Cell Lysis & Disruption Revenue Market Share by Region in 2018 VS 2022
Figure 19. Global Cell Lysis & Disruption Revenue Market Share Forecast by Region (2024-2029)
Figure 20. Global Top 10 Cell Lysis & Disruption Countries Ranking by Market Size (US$ Million) in 2022
Figure 21. Global Cell Lysis & Disruption Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 22. Global Cell Lysis & Disruption Market Share by Players in 2022
Figure 23. Global Top Cell Lysis & Disruption Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Lysis & Disruption as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Cell Lysis & Disruption Revenue in 2022
Figure 25. North America Cell Lysis & Disruption Revenue Market Share by Company in 2022
Figure 26. North America Cell Lysis & Disruption Revenue Market Share by Type (2018-2029)
Figure 27. North America Cell Lysis & Disruption Revenue Market Share by Application (2018-2029)
Figure 28. North America Cell Lysis & Disruption Revenue Share by Country (2018-2029)
Figure 29. U.S. Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 30. Canada Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 31. Europe Cell Lysis & Disruption Revenue Market Share by Company in 2022
Figure 32. Europe Cell Lysis & Disruption Revenue Market Share by Type (2018-2029)
Figure 33. Europe Cell Lysis & Disruption Revenue Market Share by Application (2018-2029)
Figure 34. Europe Cell Lysis & Disruption Revenue Share by Country (2018-2029)
Figure 35. Germany Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 36. France Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 37. U.K. Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 38. Italy Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 39. Russia Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 40. Asia Pacific Cell Lysis & Disruption Revenue Market Share by Company in 2022
Figure 41. Asia Pacific Cell Lysis & Disruption Revenue Market Share by Type (2018-2029)
Figure 42. Asia Pacific Cell Lysis & Disruption Revenue Market Share by Application (2018-2029)
Figure 43. Asia Pacific Cell Lysis & Disruption Revenue Share by Region (2018-2029)
Figure 44. China Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 45. Japan Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 46. South Korea Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 47. India Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 48. Australia Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 49. Taiwan Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 50. Indonesia Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 51. Thailand Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 52. Malaysia Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 53. Philippines Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 54. Vietnam Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 55. Latin America Cell Lysis & Disruption Revenue Market Share by Company in 2022
Figure 56. Latin America Cell Lysis & Disruption Revenue Market Share by Type (2018-2029)
Figure 57. Latin America Cell Lysis & Disruption Revenue Market Share by Application (2018-2029)
Figure 58. Latin America Cell Lysis & Disruption Revenue Share by Country (2018-2029)
Figure 59. Mexico Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 60. Brazil Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 61. Argentina Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 62. Middle East and Africa Cell Lysis & Disruption Revenue Market Share by Company in 2022
Figure 63. Middle East and Africa Cell Lysis & Disruption Revenue Market Share by Type (2018-2029)
Figure 64. Middle East and Africa Cell Lysis & Disruption Revenue Market Share by Application (2018-2029)
Figure 65. Middle East and Africa Cell Lysis & Disruption Revenue Share by Country (2018-2029)
Figure 66. Turkey Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 67. Saudi Arabia Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 68. U.A.E Cell Lysis & Disruption Revenue (2018-2029) & (US$ Million)
Figure 69. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 70. Merck KGaA Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 71. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 72. Qiagen NV Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 73. Becton Dickinson & Company (BD) Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 74. Danaher Corporation Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 75. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 76. Miltenyi Biotec GmbH Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 77. Claremont BioSolutions, LLC Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 78. Microfluidics International Corporation Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 79. Parr Instrument Company Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 80. BioVision, Inc. Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 81. Covaris, Inc. Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 82. Qsonica LLC Revenue Growth Rate in Cell Lysis & Disruption Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
